CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC)

Circular RNA-CDR1as acts as the sponge of microRNA-641 to promote osteoarthritis progression

(2020) Wei Zhang et al.   Journal of Inflammation-London

CircRNA CDR1as knockdown inhibits progression of non‐small‐cell lung cancer by regulating miR‐219a‐5p/SOX5 axis

(2020) Yaming Li et al.   Thoracic Cancer

Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR-330-5p to promote non-small cell lung cancer progression

(2020) Yuanyong Wang et al.   Translational Lung Cancer Research

MiR-130a alleviated high-glucose induced retinal pigment epithelium (RPE) death by modulating TNF-α/SOD1/ROS cascade mediated pyroptosis

(2020) Xiaoting Xi et al.   BIOMEDICINE & PHARMACOTHERAPY

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: a phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan

(2019) Satoshi Watanabe et al.   LUNG CANCER

LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in osteosarcoma through modulating miR-641/HOXA9 signaling pathway

(2019) Ning Zhang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Inhibition of circular RNA CDR1as increases chemosensitivity of 5‐FU‐resistant BC cells through up‐regulating miR‐7

(2019) Wei Yang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition

(2019) Alberto Cruz-Bermúdez et al.   FREE RADICAL BIOLOGY AND MEDICINE

Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF 1 expression through miR‐1270 inhibition

(2019) Wenbo Yuan et al.   Molecular Oncology

lncRNA Colorectal Neoplasia Differentially Expressed (CRNDE) Promotes Proliferation and Inhibits Apoptosis in Non-Small Cell Lung Cancer Cells by Regulating the miR-641/CDK6 Axis

(2019) Ya-Feng Fan et al.   MEDICAL SCIENCE MONITOR

Circular RNA Cdr1as upregulates SCAI to suppress cisplatin resistance in Ovarian Cancer via miR-1270 suppression

(2019) Zhao Zhao et al.   Molecular Therapy-Nucleic Acids

Screening miRNAs associated with resistance gemcitabine from exosomes in A549 lung cancer cells

(2019) Ai-Ling Liang et al.   Cancer Management and Research

The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p

(2019) Siliang Wei et al.   EBioMedicine

Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway

(2019) Ma-Sha Huang et al.   Frontiers in Oncology

Role of KEAP1/NFE2L2 mutations in the chemotherapeutic response of non-small cell lung cancer patients

(2019) Youngtae Jeong et al.   CLINICAL CANCER RESEARCH

Hsa_irc_0092306 targeting miR-197-3p promotes gastric cancer development by regulating PRKCB in MKN-45 cells

(2019) Zihao Chen et al.   Molecular Therapy-Nucleic Acids

Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer

(2019) Haixiang Yu et al.   Canadian Respiratory Journal

Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma

(2019) Yuqiang Mao et al.   BIOMEDICINE & PHARMACOTHERAPY

Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296–5p

(2019) Yu Dong et al.   LIFE SCIENCES

BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC

(2018) Lauren MacDonagh et al.   CANCER LETTERS

Prognostic value of Ki67 analysed by cytology or histology in primary breast cancer

(2018) Stephanie Robertson et al.   JOURNAL OF CLINICAL PATHOLOGY

miR-641 Functions as a Tumor Suppressor by Targeting MDM2 in Human Lung Cancer

(2018) Qinglong Kong et al.   ONCOLOGY RESEARCH

Overexpressed CDR1as functions as an oncogene to promote the tumor progression via miR-7 in non-small-cell lung cancer

(2018) Xiaofei Zhang et al.   OncoTargets and Therapy

Increased expression of miR-641 contributes to erlotinib resistance in non-small-cell lung cancer cells by targeting NF1

(2018) Juan Chen et al.   Cancer Medicine

TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway

(2018) Ying Xing et al.   Cell Communication and Signaling

FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC

(2018) Sisi Cao et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells

(2018) Jiwei Guo et al.   EBioMedicine

Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption

(2018) Yalin Wang et al.   Cell Death & Disease

miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC

(2018) Xiaoyuan Wang et al.   Stem Cell Research & Therapy

Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity

(2017) Lihui Wang et al.   Cell Death & Disease

Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC

(2017) Lauren MacDonagh et al.   Oncotarget

High Ki67 expression is an independent good prognostic marker in colorectal cancer

(2015) Nathaniel Melling et al.   JOURNAL OF CLINICAL PATHOLOGY

A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide

(2015) Marta Pojo et al.   Oncotarget

Alteration of gene expression and DNA methylation in drug-resistant gastric cancer

(2014) OSAMU MAEDA et al.   ONCOLOGY REPORTS